167 related articles for article (PubMed ID: 11964964)
1. Age-dependent variations in fecal calprotectin concentrations in children.
Rugtveit J; Fagerhol MK
J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):323-4; author reply 324-5. PubMed ID: 11964964
[No Abstract] [Full Text] [Related]
2. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):171-7. PubMed ID: 11321388
[TBL] [Abstract][Full Text] [Related]
3. Is fecal calprotectin the next standard in inflammatory bowel disease activity tests?
Alic M
Am J Gastroenterol; 1999 Nov; 94(11):3370-1. PubMed ID: 10566749
[No Abstract] [Full Text] [Related]
4. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children.
Olafsdottir E; Aksnes L; Fluge G; Berstad A
Acta Paediatr; 2002; 91(1):45-50. PubMed ID: 11883817
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
[TBL] [Abstract][Full Text] [Related]
6. Chronic diarrhea: to scope or not to scope?
Achkar JP
Inflamm Bowel Dis; 2001 Aug; 7(3):276-7. PubMed ID: 11515856
[No Abstract] [Full Text] [Related]
7. Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammation.
Bjarnason I; Sherwood R
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):11-3. PubMed ID: 11479401
[No Abstract] [Full Text] [Related]
8. Fecal Calprotectin as a Screening Marker for Inflammatory Bowel Disease.
Sridhar M; Kesavelu D
Indian Pediatr; 2019 Mar; 56(3):249-250. PubMed ID: 30955002
[TBL] [Abstract][Full Text] [Related]
9. Faecal calprotectin levels and colorectal neoplasia.
Brydon WG; Campbell SS; Anderson NA; Wilson RG; Ghosh S
Gut; 2001 Apr; 48(4):579-80. PubMed ID: 11288736
[No Abstract] [Full Text] [Related]
10. Improved assay for fecal calprotectin.
Tøn H; Brandsnes ; Dale S; Holtlund J; Skuibina E; Schjønsby H; Johne B
Clin Chim Acta; 2000 Feb; 292(1-2):41-54. PubMed ID: 10686275
[TBL] [Abstract][Full Text] [Related]
11. Fecal calprotectin in healthy term and preterm infants.
Nissen AC; van Gils CE; Menheere PP; Van den Neucker AM; van der Hoeven MA; Forget PP
J Pediatr Gastroenterol Nutr; 2004 Jan; 38(1):107-8. PubMed ID: 14676607
[No Abstract] [Full Text] [Related]
12. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
[TBL] [Abstract][Full Text] [Related]
13. Paediatric reference ranges for faecal calprotectin: a UK study.
Davidson F; Lock RJ
Ann Clin Biochem; 2017 Mar; 54(2):214-218. PubMed ID: 27141011
[TBL] [Abstract][Full Text] [Related]
14. Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics.
Kristinsson J; Armbruster CH; Ugstad M; Kriwanek S; Nygaard K; Tøn H; Fuglerud P
Scand J Gastroenterol; 2001 Feb; 36(2):202-7. PubMed ID: 11252414
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.
Limburg PJ; Ahlquist DA; Sandborn WJ; Mahoney DW; Devens ME; Harrington JJ; Zinsmeister AR
Am J Gastroenterol; 2000 Oct; 95(10):2831-7. PubMed ID: 11051356
[TBL] [Abstract][Full Text] [Related]
16. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
Sidler MA; Leach ST; Day AS
Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
[TBL] [Abstract][Full Text] [Related]
17. Normative Fecal Calprotectin Concentrations in Guatemalan Preschoolers Are High Relative to Children Reported Elsewhere.
Soto-Méndez MJ; Romero-Abal ME; Schümann K; Gil Á; Solomons NW
J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):238-244. PubMed ID: 27101538
[TBL] [Abstract][Full Text] [Related]
18. Immunoanalytical characteristics of fecal calprotectin.
Desbène C; Gaillard O; Kapel N
Ann Biol Clin (Paris); 2016 Dec; 74(6):725-734. PubMed ID: 27848924
[TBL] [Abstract][Full Text] [Related]
19. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
20. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm.
Husebye E; Tøn H; Johne B
Am J Gastroenterol; 2001 Sep; 96(9):2683-7. PubMed ID: 11569695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]